Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase I toxicity and pharmacology study of trimethylcolchicinic acid in patients with advanced malignanciesE Hu, R Ko, R Koda, et al.
Experientia|June 15, 1979
Immunological profile of breast cancer patients in early or advanced diseaseE Menconi, A Barzi, M Greco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2008
Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepiloneS Goel, G L Goldberg, D Y-S Kuo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Good tolerance of weekly oral idarubicin: (4-demethoxydaunorubicin): a phase I study with pharmacologyH Hochster, M Green, L Liebes, et al.
Investigational New Drugs|January 1, 1994
Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome)P Guaglianone, K Chan, E DelaFlor-Weiss, et al.
Journal of Chemotherapy (Florence, Italy)|September 15, 2007
Mucinous cancer of the appendix: challenges in diagnosis and treatmentE Andreopoulou, H Yee, M A Warycha, et al.
Cancer Treatment Reports|January 1, 1985
Single-dose dacarbazine and dactinomycin in advanced malignant melanomaH Hochster, M Levin, J Speyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Paclitaxel (Taxol) in heavily pretreated ovarian cancer: antitumor activity and complicationsB Uziely, S Groshen, S Jeffers, et al.
Journal of Chromatography. B, Biomedical Applications|November 17, 1995
High-performance liquid chromatographic method for the determination of a novel thymidylate synthase inhibitor, AG 331, in human serumW Y Li, D J Chatterjee, B V Shetty, et al.
Pageof 6